COVID-19 and how evidence of a new disease evolves

Féline P B Kroon^{1

2}, Ted R Mikuls³, Robert Bm Landewé^{4

5}

Affiliations

¹ Rheumatology, Zuyderland Medical Centre, Heerlen, The Netherlands f.kroon.reum@lumc.nl.
² Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
³ Department of Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.
⁴ Rheumatology, Zuyderland Medical Centre, Heerlen, The Netherlands.
⁵ Amsterdam Rheumatology Center, AMC, Amsterdam, The Netherlands.

Féline P B Kroon et al. Ann Rheum Dis. 2021 Mar.

. 2021 Mar;80(3):401-402.

doi: 10.1136/annrheumdis-2020-218483. Epub 2020 Aug 12.

Féline P B Kroon^{1

2}, Ted R Mikuls³, Robert Bm Landewé^{4

5}

¹ Rheumatology, Zuyderland Medical Centre, Heerlen, The Netherlands f.kroon.reum@lumc.nl.
² Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
³ Department of Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.
⁴ Rheumatology, Zuyderland Medical Centre, Heerlen, The Netherlands.
⁵ Amsterdam Rheumatology Center, AMC, Amsterdam, The Netherlands.

No abstract available

Keywords: antirheumatic agents; autoimmune diseases; communicable diseases; epidemiology; imported.

Conflict of interest statement

Competing interests: None declared.